CD73: a new biomarker in triple-negative breast cancer

被引：4
|
作者：
Lafont, Virginie [1 ,2 ]
Michaud, Henri-Alexandre [1 ,2 ]
Bonnefoy, Nathalie [1 ,2 ]
机构：
[1] INSERM, IRCM, Montpellier, France
[2] Univ Montpellier, Inst Reg Canc Montpellier ICM, Montpellier, France
来源：
TRANSLATIONAL CANCER RESEARCH | 2018年 / 7卷
关键词：
CLINICAL-SIGNIFICANCE; POOR-PROGNOSIS; EXPRESSION; CARCINOMA; MIGRATION; CELLS;
D O I：
10.21037/tcr.2018.05.22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S594 / S596
页数：3
相关论文
共 50 条
  • [1] Growth inhibition of triple-negative breast cancer cells due to the lack of CD73
    Petruk, N.
    Sandholm, J.
    Tuomela, J.
    Selander, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer
    Allard, Bertrand
    Turcotte, Martin
    Stagg, John
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (08) : 863 - 881
  • [3] CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
    Petruk, Nataliia
    Tuominen, Sanni
    Akerfelt, Malin
    Mattsson, Jesse
    Sandholm, Jouko
    Nees, Matthias
    Yegutkin, Gennady G.
    Jukkola, Arja
    Tuomela, Johanna
    Selander, Katri S.
    SCIENTIFIC REPORTS, 2021, 11 (01):
  • [4] Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer
    Cabioglu, Neslihan
    Bayram, Aysel
    Emiroglu, Selman
    Onder, Semen
    Karatay, Huseyin
    Oner, Gizem
    Tukenmez, Mustafa
    Muslumanoglu, Mahmut
    Igci, Abdullah
    Aydiner, Adnan
    Saip, Pinar
    Yavuz, Ekrem
    Ozmen, Vahit
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial
    Buisseret, L.
    Pommey, S.
    Allard, B.
    Garaud, S.
    Bergeron, M.
    Cousineau, I.
    Ameye, L.
    Bareche, Y.
    Paesmans, M.
    Crown, J. P. A.
    Di Leo, A.
    Loi, S.
    Piccart-Gebhart, M.
    Willard-Gallo, K.
    Sotiriou, C.
    Stagg, J.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 1056 - 1062
  • [6] CD73 expression and pathologic response to neoadjuvant chemotherapy in triple negative breast cancer
    Cerbelli, Bruna
    Botticelli, Andrea
    Pisano, Annalinda
    Pernazza, Angelina
    Campagna, Domenico
    De Luca, Alessandro
    Ascierto, Paolo Antonio
    Pignataro, Maria Gemma
    Pelullo, Maria
    Della Rocca, Carlo
    Marchetti, Paolo
    Fortunato, Lucio
    Costarelli, Leopoldo
    D'Amati, Giulia
    VIRCHOWS ARCHIV, 2020, 476 (04) : 569 - 576
  • [7] CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
    Loi, Sherene
    Pommey, Sandra
    Haibe-Kains, Benjamin
    Beavis, Paul A.
    Darcy, Phillip K.
    Smyth, Mark J.
    Stagg, John
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (27) : 11091 - 11096
  • [8] CD73 expression and pathologic response to neoadjuvant chemotherapy in triple negative breast cancer
    Bruna Cerbelli
    Andrea Botticelli
    Annalinda Pisano
    Angelina Pernazza
    Domenico Campagna
    Alessandro De Luca
    Paolo Antonio Ascierto
    Maria Gemma Pignataro
    Maria Pelullo
    Carlo Della Rocca
    Paolo Marchetti
    Lucio Fortunato
    Leopoldo Costarelli
    Giulia d’Amati
    Virchows Archiv, 2020, 476 : 569 - 576
  • [9] CD73 regulates zoledronate-induced lymphocyte infiltration in triple-negative breast cancer tumors and lung metastases
    Petruk, Nataliia
    Siddiqui, Arafat
    Tadayon, Sina
    Maatta, Jorma
    Mattila, Pieta K.
    Jukkola, Arja
    Sandholm, Jouko
    Selander, Katri S.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model
    Mediratta, Karan
    El-Sahli, Sara
    Marotel, Marie
    Awan, Muhammad Z.
    Kirkby, Melanie
    Salkini, Ammar
    Kurdieh, Reem
    Abdisalam, Salman
    Shrestha, Amit
    Di Censo, Chiara
    Sulaiman, Andrew
    McGarry, Sarah
    Lavoie, Jessie R.
    Liu, Zhen
    Lee, Seung-Hwan
    Li, Xuguang
    Sciume, Giuseppe
    D'Costa, Vanessa M.
    Ardolino, Michele
    Wang, Lisheng
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345